APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Site-Directed Mutagenesis Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gene Site-Directed Mutagenesis Services Industry Growth and Trends Forecast to 2032

11 April 2026113 pages

Choose your research edition.

Industry ResearchGene Site-Directed Mutagenesis Services Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Site-Directed Mutagenesis Services Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Gene Site-Directed Mutagenesis Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Site-Directed Mutagenesis Services Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Gene Site-Directed Mutagenesis Services Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

According to APO Research, the global Gene Site-Directed Mutagenesis Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gene Site-Directed Mutagenesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gene Site-Directed Mutagenesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Site-Directed Mutagenesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Gene Site-Directed Mutagenesis Services market include Azenta Life Sciences, GenScript, Thermo Fisher Scientific, Charles River Laboratories, Genewiz, Creative Biolabs, NovoPro Bioscience Inc., ACGT, Inc. and Epoch Life Science, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gene Site-Directed Mutagenesis Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gene Site-Directed Mutagenesis Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gene Site-Directed Mutagenesis Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gene Site-Directed Mutagenesis Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Gene Site-Directed Mutagenesis Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gene Site-Directed Mutagenesis Services Market by Company

Azenta Life Sciences

GenScript

Thermo Fisher Scientific

Charles River Laboratories

Genewiz

Creative Biolabs

NovoPro Bioscience Inc.

ACGT, Inc.

Epoch Life Science

Eurofins Genomics

NZYtech

Synbio Technologies

Tsingke

GenCefe

Generay

Gene Site-Directed Mutagenesis Services Segment by Type

Synonymous Mutations

Missense Mutation

Nonsense Mutation

Gene Site-Directed Mutagenesis Services Segment by Application

Medical Industry

Biological Research

Others

Gene Site-Directed Mutagenesis Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Site-Directed Mutagenesis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Site-Directed Mutagenesis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Site-Directed Mutagenesis Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Gene Site-Directed Mutagenesis Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Gene Site-Directed Mutagenesis Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Gene Site-Directed Mutagenesis Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Gene Site-Directed Mutagenesis Services Market Share by Region (2021-2026) Table 4. Global Gene Site-Directed Mutagenesis Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Gene Site-Directed Mutagenesis Services Market Share by Region (2027-2032) Table 6. Global Gene Site-Directed Mutagenesis Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Gene Site-Directed Mutagenesis Services Market Size Share by Type (2021-2026) Table 9. Global Gene Site-Directed Mutagenesis Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Gene Site-Directed Mutagenesis Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Gene Site-Directed Mutagenesis Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Gene Site-Directed Mutagenesis Services Market Size Share by Application (2021-2026) Table 24. Global Gene Site-Directed Mutagenesis Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Gene Site-Directed Mutagenesis Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Gene Site-Directed Mutagenesis Services Industry Trends Table 37. Gene Site-Directed Mutagenesis Services Industry Drivers Table 38. Gene Site-Directed Mutagenesis Services Industry Opportunities and Challenges Table 39. Gene Site-Directed Mutagenesis Services Industry Restraints Table 40. Global Gene Site-Directed Mutagenesis Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Company (2021-2026) Table 42. Global Gene Site-Directed Mutagenesis Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Gene Site-Directed Mutagenesis Services Key Company Headquarters & Area Served Table 44. Global Gene Site-Directed Mutagenesis Services Company, Product Type & Application Table 45. Global Gene Site-Directed Mutagenesis Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Gene Site-Directed Mutagenesis Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Azenta Life Sciences Company Information Table 49. Azenta Life Sciences Business Overview Table 50. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product Portfolio Table 52. Azenta Life Sciences Recent Development Table 53. GenScript Company Information Table 54. GenScript Business Overview Table 55. GenScript Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. GenScript Gene Site-Directed Mutagenesis Services Product Portfolio Table 57. GenScript Recent Development Table 58. Thermo Fisher Scientific Company Information Table 59. Thermo Fisher Scientific Business Overview Table 60. Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Product Portfolio Table 62. Thermo Fisher Scientific Recent Development Table 63. Charles River Laboratories Company Information Table 64. Charles River Laboratories Business Overview Table 65. Charles River Laboratories Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Charles River Laboratories Gene Site-Directed Mutagenesis Services Product Portfolio Table 67. Charles River Laboratories Recent Development Table 68. Genewiz Company Information Table 69. Genewiz Business Overview Table 70. Genewiz Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Genewiz Gene Site-Directed Mutagenesis Services Product Portfolio Table 72. Genewiz Recent Development Table 73. Creative Biolabs Company Information Table 74. Creative Biolabs Business Overview Table 75. Creative Biolabs Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Creative Biolabs Gene Site-Directed Mutagenesis Services Product Portfolio Table 77. Creative Biolabs Recent Development Table 78. NovoPro Bioscience Inc. Company Information Table 79. NovoPro Bioscience Inc. Business Overview Table 80. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product Portfolio Table 82. NovoPro Bioscience Inc. Recent Development Table 83. ACGT, Inc. Company Information Table 84. ACGT, Inc. Business Overview Table 85. ACGT, Inc. Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. ACGT, Inc. Gene Site-Directed Mutagenesis Services Product Portfolio Table 87. ACGT, Inc. Recent Development Table 88. Epoch Life Science Company Information Table 89. Epoch Life Science Business Overview Table 90. Epoch Life Science Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Epoch Life Science Gene Site-Directed Mutagenesis Services Product Portfolio Table 92. Epoch Life Science Recent Development Table 93. Eurofins Genomics Company Information Table 94. Eurofins Genomics Business Overview Table 95. Eurofins Genomics Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Eurofins Genomics Gene Site-Directed Mutagenesis Services Product Portfolio Table 97. Eurofins Genomics Recent Development Table 98. NZYtech Company Information Table 99. NZYtech Business Overview Table 100. NZYtech Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. NZYtech Gene Site-Directed Mutagenesis Services Product Portfolio Table 102. NZYtech Recent Development Table 103. Synbio Technologies Company Information Table 104. Synbio Technologies Business Overview Table 105. Synbio Technologies Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Synbio Technologies Gene Site-Directed Mutagenesis Services Product Portfolio Table 107. Synbio Technologies Recent Development Table 108. Tsingke Company Information Table 109. Tsingke Business Overview Table 110. Tsingke Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Tsingke Gene Site-Directed Mutagenesis Services Product Portfolio Table 112. Tsingke Recent Development Table 113. GenCefe Company Information Table 114. GenCefe Business Overview Table 115. GenCefe Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. GenCefe Gene Site-Directed Mutagenesis Services Product Portfolio Table 117. GenCefe Recent Development Table 118. Generay Company Information Table 119. Generay Business Overview Table 120. Generay Gene Site-Directed Mutagenesis Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Generay Gene Site-Directed Mutagenesis Services Product Portfolio Table 122. Generay Recent Development Table 123. North America Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2026) Table 126. North America Gene Site-Directed Mutagenesis Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Gene Site-Directed Mutagenesis Services Market Share Forecast by Country (2027-2032) Table 128. Europe Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2026) Table 131. Europe Gene Site-Directed Mutagenesis Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Gene Site-Directed Mutagenesis Services Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2026) Table 136. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share Forecast by Country (2027-2032) Table 138. Latin America Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2026) Table 141. Latin America Gene Site-Directed Mutagenesis Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Gene Site-Directed Mutagenesis Services Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2026) Table 146. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Gene Site-Directed Mutagenesis Services Product Image Figure 3. Global Gene Site-Directed Mutagenesis Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Gene Site-Directed Mutagenesis Services Market Share by Region: 2025 VS 2032 Figure 6. Global Gene Site-Directed Mutagenesis Services Market Share by Region (2021-2032) Figure 7. North America Gene Site-Directed Mutagenesis Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Gene Site-Directed Mutagenesis Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Gene Site-Directed Mutagenesis Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Synonymous Mutations Image Figure 13. Global Synonymous Mutations Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Missense Mutation Image Figure 15. Global Missense Mutation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Nonsense Mutation Image Figure 17. Global Nonsense Mutation Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Gene Site-Directed Mutagenesis Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Gene Site-Directed Mutagenesis Services Market Share by Type 2025 VS 2032 Figure 20. North America Gene Site-Directed Mutagenesis Services Market Size Share by Type (2021-2032) Figure 21. Europe Gene Site-Directed Mutagenesis Services Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Share by Type (2021-2032) Figure 23. Latin America Gene Site-Directed Mutagenesis Services Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size Share by Type (2021-2032) Figure 25. Medical Industry Image Figure 26. Global Medical Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Biological Research Image Figure 28. Global Biological Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Gene Site-Directed Mutagenesis Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Gene Site-Directed Mutagenesis Services Market Share by Application 2025 VS 2032 Figure 33. North America Gene Site-Directed Mutagenesis Services Market Size Share by Application (2021-2032) Figure 34. Europe Gene Site-Directed Mutagenesis Services Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Share by Application (2021-2032) Figure 36. Latin America Gene Site-Directed Mutagenesis Services Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Gene Site-Directed Mutagenesis Services Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Gene Site-Directed Mutagenesis Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Gene Site-Directed Mutagenesis Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032) Figure 43. Europe Gene Site-Directed Mutagenesis Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Gene Site-Directed Mutagenesis Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032) Figure 46. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032) Figure 49. Latin America Gene Site-Directed Mutagenesis Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Gene Site-Directed Mutagenesis Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032) Figure 52. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Synonymous Mutations
  • Missense Mutation
  • Nonsense Mutation
Applications
  • Medical Industry
  • Biological Research
  • Others
Companies covered
  • Azenta Life Sciences
  • GenScript
  • Thermo Fisher Scientific
  • Charles River Laboratories
  • Genewiz
  • Creative Biolabs
  • NovoPro Bioscience Inc.
  • ACGT, Inc.
  • Epoch Life Science
  • Eurofins Genomics
  • NZYtech
  • Synbio Technologies
  • Tsingke
  • GenCefe
  • Generay

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Gene Site-Directed Mutagenesis Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Gene Site-Directed Mutagenesis Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Gene Site-Directed Mutagenesis Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Gene Site-Directed Mutagenesis Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Gene Site-Directed Mutagenesis Services Market Size (2021-2032)
  8. 1.5.1 North America Gene Site-Directed Mutagenesis Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Gene Site-Directed Mutagenesis Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Gene Site-Directed Mutagenesis Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size Growth Rate (2021-2032)
2 Gene Site-Directed Mutagenesis Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Synonymous Mutations
  3. 2.1.2 Missense Mutation
  4. 2.1.3 Nonsense Mutation
  5. 2.2 Global Gene Site-Directed Mutagenesis Services Market Size by Type
  6. 2.2.1 Global Gene Site-Directed Mutagenesis Services Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Gene Site-Directed Mutagenesis Services Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Gene Site-Directed Mutagenesis Services Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Gene Site-Directed Mutagenesis Services Market Size by Regions
  10. 2.3.1 North America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size Breakdown by Type (2021-2026)
3 Gene Site-Directed Mutagenesis Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Medical Industry
  3. 3.1.2 Biological Research
  4. 3.1.3 Others
  5. 3.2 Global Gene Site-Directed Mutagenesis Services Market Size by Application
  6. 3.2.1 Global Gene Site-Directed Mutagenesis Services Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Gene Site-Directed Mutagenesis Services Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Gene Site-Directed Mutagenesis Services Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Gene Site-Directed Mutagenesis Services Market Size by Regions
  10. 3.3.1 North America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Gene Site-Directed Mutagenesis Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Gene Site-Directed Mutagenesis Services Industry Trends
  2. 4.2 Gene Site-Directed Mutagenesis Services Industry Drivers
  3. 4.3 Gene Site-Directed Mutagenesis Services Industry Opportunities and Challenges
  4. 4.4 Gene Site-Directed Mutagenesis Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Gene Site-Directed Mutagenesis Services Revenue (2021-2026)
  2. 5.2 Global Gene Site-Directed Mutagenesis Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Gene Site-Directed Mutagenesis Services Key Company Headquarters & Area Served
  4. 5.4 Global Gene Site-Directed Mutagenesis Services Company, Product Type & Application
  5. 5.5 Global Gene Site-Directed Mutagenesis Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Gene Site-Directed Mutagenesis Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Gene Site-Directed Mutagenesis Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Gene Site-Directed Mutagenesis Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Azenta Life Sciences
  2. 6.1.1 Azenta Life Sciences Company Information
  3. 6.1.2 Azenta Life Sciences Business Overview
  4. 6.1.3 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product Portfolio
  6. 6.1.5 Azenta Life Sciences Recent Developments
  7. 6.2 GenScript
  8. 6.2.1 GenScript Company Information
  9. 6.2.2 GenScript Business Overview
  10. 6.2.3 GenScript Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 GenScript Gene Site-Directed Mutagenesis Services Product Portfolio
  12. 6.2.5 GenScript Recent Developments
  13. 6.3 Thermo Fisher Scientific
  14. 6.3.1 Thermo Fisher Scientific Company Information
  15. 6.3.2 Thermo Fisher Scientific Business Overview
  16. 6.3.3 Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Product Portfolio
  18. 6.3.5 Thermo Fisher Scientific Recent Developments
  19. 6.4 Charles River Laboratories
  20. 6.4.1 Charles River Laboratories Company Information
  21. 6.4.2 Charles River Laboratories Business Overview
  22. 6.4.3 Charles River Laboratories Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Charles River Laboratories Gene Site-Directed Mutagenesis Services Product Portfolio
  24. 6.4.5 Charles River Laboratories Recent Developments
  25. 6.5 Genewiz
  26. 6.5.1 Genewiz Company Information
  27. 6.5.2 Genewiz Business Overview
  28. 6.5.3 Genewiz Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Genewiz Gene Site-Directed Mutagenesis Services Product Portfolio
  30. 6.5.5 Genewiz Recent Developments
  31. 6.6 Creative Biolabs
  32. 6.6.1 Creative Biolabs Company Information
  33. 6.6.2 Creative Biolabs Business Overview
  34. 6.6.3 Creative Biolabs Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Creative Biolabs Gene Site-Directed Mutagenesis Services Product Portfolio
  36. 6.6.5 Creative Biolabs Recent Developments
  37. 6.7 NovoPro Bioscience Inc.
  38. 6.7.1 NovoPro Bioscience Inc. Company Information
  39. 6.7.2 NovoPro Bioscience Inc. Business Overview
  40. 6.7.3 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product Portfolio
  42. 6.7.5 NovoPro Bioscience Inc. Recent Developments
  43. 6.8 ACGT, Inc.
  44. 6.8.1 ACGT, Inc. Company Information
  45. 6.8.2 ACGT, Inc. Business Overview
  46. 6.8.3 ACGT, Inc. Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 ACGT, Inc. Gene Site-Directed Mutagenesis Services Product Portfolio
  48. 6.8.5 ACGT, Inc. Recent Developments
  49. 6.9 Epoch Life Science
  50. 6.9.1 Epoch Life Science Company Information
  51. 6.9.2 Epoch Life Science Business Overview
  52. 6.9.3 Epoch Life Science Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Epoch Life Science Gene Site-Directed Mutagenesis Services Product Portfolio
  54. 6.9.5 Epoch Life Science Recent Developments
  55. 6.10 Eurofins Genomics
  56. 6.10.1 Eurofins Genomics Company Information
  57. 6.10.2 Eurofins Genomics Business Overview
  58. 6.10.3 Eurofins Genomics Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Eurofins Genomics Gene Site-Directed Mutagenesis Services Product Portfolio
  60. 6.10.5 Eurofins Genomics Recent Developments
  61. 6.11 NZYtech
  62. 6.11.1 NZYtech Company Information
  63. 6.11.2 NZYtech Business Overview
  64. 6.11.3 NZYtech Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 NZYtech Gene Site-Directed Mutagenesis Services Product Portfolio
  66. 6.11.5 NZYtech Recent Developments
  67. 6.12 Synbio Technologies
  68. 6.12.1 Synbio Technologies Company Information
  69. 6.12.2 Synbio Technologies Business Overview
  70. 6.12.3 Synbio Technologies Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Synbio Technologies Gene Site-Directed Mutagenesis Services Product Portfolio
  72. 6.12.5 Synbio Technologies Recent Developments
  73. 6.13 Tsingke
  74. 6.13.1 Tsingke Company Information
  75. 6.13.2 Tsingke Business Overview
  76. 6.13.3 Tsingke Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Tsingke Gene Site-Directed Mutagenesis Services Product Portfolio
  78. 6.13.5 Tsingke Recent Developments
  79. 6.14 GenCefe
  80. 6.14.1 GenCefe Company Information
  81. 6.14.2 GenCefe Business Overview
  82. 6.14.3 GenCefe Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 GenCefe Gene Site-Directed Mutagenesis Services Product Portfolio
  84. 6.14.5 GenCefe Recent Developments
  85. 6.15 Generay
  86. 6.15.1 Generay Company Information
  87. 6.15.2 Generay Business Overview
  88. 6.15.3 Generay Gene Site-Directed Mutagenesis Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Generay Gene Site-Directed Mutagenesis Services Product Portfolio
  90. 6.15.5 Generay Recent Developments
7 North America
  1. 7.1 North America Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026)
  3. 7.3 North America Gene Site-Directed Mutagenesis Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026)
  3. 8.3 Europe Gene Site-Directed Mutagenesis Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Gene Site-Directed Mutagenesis Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026)
  3. 10.3 South America Gene Site-Directed Mutagenesis Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst